1. The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC)
   Thomas Muley et al, 2018, Lung Cancer CrossRef
2. Prognostic value of baseline carcinoembryonic antigen and cytokeratin 19 fragment levels in advanced non-small cell lung cancer
   Ae Rin Baek et al, 2018, Cancer Biomarkers CrossRef
3. Highly sensitive carboxyl-graphene oxide-based surface plasmon resonance immunosensor for the detection of lung cancer for cytokeratin 19 biomarker in human plasma
   Nan-Fu Chiu et al, 2018, Sensors and Actuators B: Chemical CrossRef
4. AuNPs and 2D functional nanomaterial-assisted SPR development for the cancer detection: a critical review
   Chen Chen et al, 2022, Cancer Nanotechnology CrossRef
5. Pulmonary pleomorphic carcinoma with pseudoprogression during nivolumab therapy and the usefulness of tumor markers: A case report
   Akihiro Yoshimura et al, 2018, Clinical Case Reports CrossRef
6. Association of Serum Levels of CEA, CA199, CA125, CYFRA21-1 and CA72-4 and Disease Characteristics in Colorectal Cancer
   Wa Zhong et al, 2015, Pathology & Oncology Research CrossRef
7. Oncogenic function of TUSC3 in non-small cell lung cancer is associated with Hedgehog signalling pathway
   Ye Gu et al, 2017, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
8. Detection of non-small cell lung cancer marker CYFRA21-1 via Mxene-based immunoelectrochemical sensor
   Dong Li et al, 2023, International Journal of Electrochemical Science CrossRef
9. Fibroblast phenotypes in different lung diseases
   Heng Du et al, 2014, Journal of Cardiothoracic Surgery CrossRef
10. Clinical Evaluation and Therapeutic Monitoring Value of Serum Tumor Markers in Lung Cancer
    Lishui Wang et al, 2016, The International Journal of Biological Markers CrossRef
11. Carcinoembryonic antigen and cytokeratin-19 fragments for assessment of therapy response in non-small cell lung cancer: a systematic review and meta-analysis
    Stefan Holdenrieder et al, 2017, British Journal of Cancer CrossRef
12. Platelet-to-Lymphocyte Ratio Multiplied by the Cytokeratin-19 Fragment Level as a Predictor of Pathological Response to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma
    Yuji Shishido et al, 2021, Yonago Acta Medica CrossRef